Literature DB >> 15072833

Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells.

Brett M Hall1, James E Fortney, Lela Taylor, Hillary Wood, Lin Wang, Scott Adams, Suzanne Davis, Laura F Gibson.   

Abstract

In the current study we generated murine bone marrow stromal cells that constitutively express human VCAM-1. These stromal cell lines allow investigation of the contribution of VCAM-1 initiated signaling to tumor cell survival. Co-culture of ALL cell lines with stromal cells engineered to over express VCAM-1 enhanced survival of leukemic cells in a PI-3 kinase-dependent manner, compared to co-culture with parental stromal cells expressing only endogenous VCAM-1. These observations suggest that modulation of stromal cell VCAM-1 by specific chemotherapeutic drugs may have utility in decreasing residual disease. In addition, these novel lines provide an in vitro model in which other tumor types that interact with stromal cells in the bone marrow microenvironment may be evaluated to determine the contribution of VCAM-1 initiated signaling to modulation of treatment response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072833     DOI: 10.1016/j.canlet.2003.10.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Authors:  Audrey N Jajosky; James E Coad; Jeffrey A Vos; Karen H Martin; Jamie R Senft; Sharon L Wenger; Laura F Gibson
Journal:  Stem Cells Transl Med       Date:  2014-05-22       Impact factor: 6.940

2.  Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia.

Authors:  Blake S Moses; Rebecca Evans; William L Slone; Debbie Piktel; Ivan Martinez; Michael D Craig; Laura F Gibson
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

3.  Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.

Authors:  Stephen M Akers; Stephanie L Rellick; James E Fortney; Laura F Gibson
Journal:  Leuk Res       Date:  2011-01-26       Impact factor: 3.156

4.  VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis.

Authors:  Heather O'Leary; Stephen M Akers; Debra Piktel; Cheryl Walton; James E Fortney; Karen H Martin; Michael Craig; James Coad; Laura F Gibson
Journal:  Cancer Microenviron       Date:  2010-03-02

5.  Exosomes derived from bone marrow stromal cells decrease the sensitivity of leukemic cells to etoposide.

Authors:  Jianling Wang; Dong Li; Yong Zhuang; Jinqiu Fu; Xue Li; Qing Shi; Xiuli Ju
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

6.  Hematopoietic derived cell infiltration of the intestinal tumor microenvironment in Apc Min/+ mice.

Authors:  Celestia Davis; Robert Price; Grishma Acharya; Troy Baudino; Thomas Borg; Franklin G Berger; Maria Marjorette O Peña
Journal:  Microsc Microanal       Date:  2011-04-08       Impact factor: 4.127

Review 7.  The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies.

Authors:  K H Shain; J Tao
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

8.  Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell-cell contact to activate the Jagged1/Notch1 pathway.

Authors:  Ji-Wen Cheng; Li-Xia Duan; Yang Yu; Pu Wang; Jia-le Feng; Guan-Zheng Feng; Yan Liu
Journal:  Cell Biosci       Date:  2021-05-17       Impact factor: 7.133

9.  The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth.

Authors:  Zhipeng Han; Yingying Jing; Shanshan Zhang; Yan Liu; Yufang Shi; Lixin Wei
Journal:  Cell Biosci       Date:  2012-03-05       Impact factor: 7.133

10.  Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells.

Authors:  Zhipeng Han; Zhiqiang Tian; Gang Lv; Li Zhang; Guocheng Jiang; Kai Sun; Chenyang Wang; Xinxin Bu; Rong Li; Yufang Shi; Mengchao Wu; Lixin Wei
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.